Feng S - Search Results

1

Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.

Wei X, Jiang Y, Zhang X, Feng S, Zhou B, Ye X, Xing H, Xu Y, Shi J, Guo W, Zhou D, Zhang H, Sun H, Huang C, Lu C, Zheng Y, Meng Y, Huang B, Cong W, Lau WY, Cheng S. Wei X, et al. Among authors: feng s. J Clin Oncol. 2019 Aug 20;37(24):2141-2151. doi: 10.1200/JCO.18.02184. Epub 2019 Jul 8. J Clin Oncol. 2019. PMID: 31283409 Free PMC article. Clinical Trial.

2

Association of ADRB1 gene polymorphisms with pain sensitivity in a Chinese population.

Feng S, Li N, Xu S, Wang H, Yu W, Lu Y, Cao J, Meng Y. Feng S, et al. Int J Clin Exp Med. 2015 Jul 15;8(7):11514-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379972 Free PMC article.

3

Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy.

Li N, Feng S, Xue J, Wei XB, Shi J, Guo WX, Lau WY, Wu MC, Cheng SQ, Meng Y. Li N, et al. Among authors: feng s. HPB (Oxford). 2016 Jun;18(6):549-56. doi: 10.1016/j.hpb.2016.04.003. Epub 2016 May 7. HPB (Oxford). 2016. PMID: 27317960 Free PMC article.

4

A Multidisciplinary Team Approach to the Management of Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Cheng S, Wei X, Shi J, Guo W, Feng S, Zhai J, Huang B. Cheng S, et al. Among authors: feng s. Oncologist. 2020 Jun;25(6):e998. doi: 10.1634/theoncologist.2019-0196. Epub 2020 Mar 6. Oncologist. 2020. PMID: 32141691 Free PMC article.

5

Investigation of Plasma cell-free cancer genome chromosomal instability as a tool for targeted minimally invasive biomarkers for primary liver cancer diagnoses.

Feng S, Ding Z, Wang J, Qian Z, Li S, Zhang C, Xin H, Liu S, Ding G, Hu M, Meng Y, Li N. Feng S, et al. Cancer Med. 2020 Jul;9(14):5075-5085. doi: 10.1002/cam4.3142. Epub 2020 May 27. Cancer Med. 2020. PMID: 32458568 Free PMC article.

6

Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis.

Chen ZH, Zhang XP, Feng S, Feng JK, Chai ZT, Guo WX, Shi J, Lau WY, Meng Y, Cheng SQ. Chen ZH, et al. Among authors: feng s, feng jk. Hepatobiliary Surg Nutr. 2021 Oct;10(5):646-660. doi: 10.21037/hbsn.2020.03.20. Hepatobiliary Surg Nutr. 2021. PMID: 34760968 Free PMC article.

7

Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory.

Xiang YJ, Wang K, Zheng YT, Feng S, Yu HM, Li XW, Cheng X, Cheng YQ, Feng JK, Zhou LP, Meng Y, Zhai J, Shan YF, Cheng SQ. Xiang YJ, et al. Among authors: feng s, feng jk. Front Oncol. 2022 Mar 21;12:839605. doi: 10.3389/fonc.2022.839605. eCollection 2022. Front Oncol. 2022. PMID: 35387113 Free PMC article.

8

Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial.

Wang K, Yu HM, Xiang YJ, Cheng YQ, Ni QZ, Guo WX, Shi J, Feng S, Zhai J, Cheng SQ. Wang K, et al. Among authors: feng s. Future Oncol. 2022 Sep;18(30):3367-3375. doi: 10.2217/fon-2022-0188. Epub 2022 Aug 15. Future Oncol. 2022. PMID: 35968836

9

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).

Sun J, Guo R, Bi X, Wu M, Tang Z, Lau WY, Zheng S, Wang X, Yu J, Chen X, Fan J, Dong J, Chen Y, Cui Y, Dai C, Fang C, Feng S, Ji Z, Jia W, Jia N, Li G, Li J, Li Q, Li J, Liang T, Liu L, Lu S, Lv Y, Mao Y, Meng Y, Meng Z, Shen F, Shi J, Sun H, Tao K, Teng G, Wan X, Wen T, Wu L, Xia J, Ying M, Zhai J, Zhang L, Zhang X, Zhang Z, Zhao H, Zheng D, Zhi X, Zhou J, Zhou C, Zhou J, Zeng Z, Zhu K, Chen M, Cai J, Cheng S. Sun J, et al. Among authors: feng s. Liver Cancer. 2022 Mar 17;11(4):315-328. doi: 10.1159/000523997. eCollection 2022 Jul. Liver Cancer. 2022. PMID: 35978596 Free PMC article.

10

Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial.

Guo L, Wei X, Feng S, Zhai J, Guo W, Shi J, Lau WY, Meng Y, Cheng S. Guo L, et al. Among authors: feng s. Hepatol Int. 2022 Dec;16(6):1368-1378. doi: 10.1007/s12072-022-10423-7. Epub 2022 Oct 21. Hepatol Int. 2022. PMID: 36271176 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,009 results

Search Page